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Population and insemination studies indicate that women
experience declining fertility with ageing. The question
therefore arises whether older women are suitable oocyte
donors. This study addresses this issue by eTnmining the
relationship between oocyte donor age and clinical outcome
in a large oocyte donation programme. We retrospectively
reviewed data from 458 consecutive oocyte donation cycles
completed by 164 different designated oocyte donors. Data
were divided into two groups: group A, cycles with donors
aged 21-30 years at the time of follicular aspiration (193
cycles, 88 donors); and group B, cycles with donors aged
31-40 years at the time of follicular aspiration (265 cycles,
86 donors). Five donors, because of ageing during repetitive
donations, contributed data to groups A and B. In a given
cycle, all oocytes for a recipient came from only one
designated donor. Comparing the two donor groups, there
was no difference in the amount of gonadotrophin used to
achieve optimal stimulation; however, more oocytes were
obtained from group A than group B donors (16.8 ± 6.9
and 15.1 ± 8.1 respectively, P < 0.05). Similar percentages
of oocytes were fertilized in each group, resulting in the
transfer of comparable numbers of embryos (4.5 ± 1.1
and 4.4 ± 13 respectively). Comparable clinical pregnancy
rates were achieved (group A, 36%; group B, 37%). The
spontaneous abortion rates were also similar (group A,
20%; group B, 12%), resulting in comparable ongoing and
delivered pregnancy rates per cycle (group A, 29%; group
B, 32%) and per embryo transferred (group A, 6.4%;
group B, 73%). In conclusion, women of proven fertility
should not be excluded from donating oocytes simply
because of their age. There exists a cohort of fertile
women who resist the decreasing fecundity and increasing
spontaneous abortion rates associated with ageing. With
careful screening, many women of proven fertility can
donate oocytes until the age of 40 years with an efficacy
equal to that of younger women. Given the relative shortage
of suitable oocyte donors, and increasing requests from
recipients with previous donor oocyte babies to obtain
oocytes from the same, now older, donor, the findings of
this study are of practical clinical importance.
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Introduction
Oocyte donation is a successful and increasingly popular
treatment of age-related female infertility. In 1993, 135 pro-
grammes in the USA and Canada reported using donor oocytes
in 2446 cycles. Both endometrial receptivity and oocyte/
embryo quality are enhanced, resulting consistently in the
highest pregnancy rates of any assisted reproductive technique
[Society for Assisted Reproductive Technology, American
Society for Reproductive Medicine (SART), 1995]. Exogenous
hormone replacement prepares the endometria of functionally
agonadal women in their third, fourth and fifth decades of life
for pregnancy (Antinori et al., 1993; Meldrum, 1993; Pantos
et al, 1993; Sauer et al, 1993; Balmaceda et al, 1994;
Navot et al, 1994; Pados et al, 1994; Borini et al, 1995).
Furthermore, detrimental effects of ovarian stimulation and
premature luteinization on the endometrium are avoided
(Paulson et al, 1990; Hofmann et al, 1993; Legro et al,
1993). Oocyte and subsequent embryo quality are optimized
by obtaining donor oocytes from young women, commonly
with proven fertility. As data accumulate, it is possible to
define factors that influence success. Data gathered from
population studies and artificial insemination programmes
suggest a decline in female fecundity after the age of 30 years
(Tietze, 1957; Schwartz et al, 1982; van Noord-Zaadstra et al,
1991; Shenfield et al, 1993). In-vitro fertilization observations
also indicate diminishing oocyte and embryo quality with age
(Tan et al., 1992; SART, 1995). This study examines the
relationship between oocyte donor age and clinical outcome
in assisted reproduction.
Materials and methods
We retrospectively reviewed data from 458 consecutive oocyte
donation cycles completed by 164 different designated oocyte donors
between 1988 and February 1995. The protocol for oocyte donation
was reviewed and approved by the institutional review board of the
California Medical CenteT, Los Angeles, CA, USA. Data were divided
into two groups: group A, cycles with donors aged 21-30 years at
the time of follicular aspiration (193 cycles, 88 donors); and group
B, cycles with donors aged 31-40 years at the time of follicular
aspiration (265 cycles, 86 donors) (Figure 1). Five donors, by ageing
during repetitive donation, contributed data to both groups. In a given
cycle, all oocytes for a recipient came from only one designated
donor. The majority of cycles in both groups involved the anonymous
donation of oocytes (group A, 82%; group B, 69%). In no case were
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Figure 1. Data were divided into two groups: group A, cycles with donors aged 21-30 years at the time of follicular aspiration; and group
B, cycles with donors aged 31^40 years at the time of follicular aspiration.
oocytes used from infertile women undergoing assisted reproduction.
It is our general policy to accept anonymous donors up to the age of
35 years. For recipients providing their own oocyte donor, the age
restriction is 40 years. In addition to recommended screening tests
(American Fertility Society, 1993), we have been measuring the
menstrual cycle day 3 follicle stimulating hormone concentrations of
potential donors. To be accepted as a donor, the concentration must
be <15 IU/1.
Oocyte donors underwent standardized ovarian stimulation and
transvaginal sonographically guided aspiration. Embryo recipients
received an established regimen of exogenous oestrogen and progester-
one (Sauer, 1995). A total of 334 different recipients received oocytes
from the 458 donor cycles: 167 different recipients had embryos
transferred from the 193 donor cycles in group A, while 185 different
recipients received embryos from the 265 donor cycles in group B.
Some 18 recipients received embryos from a donor in groups A and
B during different cycles. All embryos were transferred transcervicaUy
into the uterine cavity 48-72 h after aspiration. No transfers involving
cryoprcserved embryos were included in this analysis.
Statistics consisted of a x2 analysis and Student's r-test Numbers
are presented as means ± SD. Significance was denned as P < 0.05.
Table L Donor response to ovarian stimulation: clinical efficacy of resultant
oocytes/embryos
Group A cycles Group B cycles
(n = 193) (n = 265)
P
value
No. of vials of gonadotrophins 28.6 ± 5.6
per cycle (75 IU per vial)
No. of oocytes per cycle 16.8 ± 6.9
Percentage of oocytes fertilized 52.6 ± 20.8
per cycle (%)
No. of embryos transferred per 4.53 ±1.11
cycle
Clinical pregnancy rate per 36.3 (n = 70)
cycle (%)
Spontaneous abortion rale per 20.0 (n = 14)
clinical pregnancy (%)
Ongoing and delivered 29.0 (n = 56)
pregnancy rate per cycle (%)
Ongoing and delivered 6.4


























By definition, donors in groups A and B differed in age (26.6
± 1.8 and 34.2 ± 1.4 years respectively; P < 0.01). Group
A women had significantly less gravidity (group A, 1.68 ±
0.89; group B, 2.86 ± 0.87; P < 0.01) and parity (group A,
1.22 ± 0.76; group B, 2.12 ± 0.66; P < 0.01) when compared
with group B women. There were no significant differences
in the number of prior spontaneous abortions in the two groups
(group A, 0.17 ± 0.34; group B, 0.25 ± 0.36; P = 0.13).
Women in group A donated fewer times than those in group
B (2.8 ± 1.8 versus 3.8 ± 3.6; P < 0.05).
. Recipients receiving oocytes from donor group A and
recipients receiving oocytes from donor group B were similar
in age (42.6 ± 6.5 and 41.4 ± 6.8 years respectively; P =
0.09), gravidity (1.45 ± 1.65 and 1.44 ± 1.47 respectively;
P = 0.9), parity (0.57 ± 1.03 and 0.50 ± 0.87 respectively;
P = 0.5) and history of spontaneous abortions (0.42 ± 0.75
and 0.49 ± 0.82 respectively; P = 0.4). Recipients were also
similar in the average number of cycles performed (group A,
1.41 ± 1.39; group B, 1.56 ± 1.49; P = 0.3).
A comparison of donor groups A and B in response to
ovarian stimulation and the clinical efficacy of the resultant
oocytes/embryos are listed in Table I. There was no difference
in the amount of gonadotrophin used to achieve optimal
stimulation, however more oocytes were obtained from group
A than group B donors. Donor semen was utilized in 12% of
the cycles in group A and 8% in group B (P = 0.2). Semen
of comparable average sperm count (group A, 97 ± 100X106/
ml; group B, 102 ± 76XlQ^/mi; P = 0.5) and percentage
motility (group A, 62 ± 18%; group B, 65 ± 19%; P = 0.1)
were used to fertilize the oocytes. Similar percentage of oocytes
were fertilized in each group, resulting in the transfer of
comparable numbers of embryos. Comparable clinical preg-






















also similar, resulting in comparable ongoing and delivered
pregnancy rates per cycle and per embryo transferred.
The database was divided into two groups only, with each
group containing data from oocytes donated by women within
a 10 year age range. Given the sample size of 458 total cycles
and designating a = 0.05, the power of detecting a difference
of 10% in the clinical pregnancy rate, the spontaneous abortion
rate or the ongoing/delivered rate was 0.71. The power of
detecting a difference of 15% was 0.99.
If data were analysed in smaller groupings, e.g. if data in
group A were subdivided further into two groups, Al (cycles
in which donors were aged between 21 and 25 years at the
time of oocyte donation; n = 64) and A2 (cycles in which
donors were aged between 26 and 30 years; n = 129), and
data in group B were subdivided further into two groups, Bl
(cycles in which donors were aged between 31 and 35 years
at the time of oocyte donation; n = 195) and B2 (cycles in
which donors were aged between 36 and 40 years; n = 70),
similar results were also observed. There was no significant
difference in the clinical pregnancy rates (groups Al, A2, Bl
and B2, 39, 35, 37 and 37% respectively), the spontaneous
abortion rates (24, 18, 11 and 15% respectively) and the
ongoing and delivered rates (30, 29, 33 and 31% respectively)
between the age subgroups. However, die power of detecting
a difference was considerably less, reflecting the diminution
of power with less data (e.g. the power of determining a
difference of 10% would only be -0.46).
Discussion
It has been suggested that oocytes donated by women =£30
years of age result in superior pregnancy rates compared wim
oocytes retrieved from women aged 31—39 years (Rotsztejn
et al, 1992; Balmaceda et al, 1994). This conclusion is not
supported by the findings of this study. Although women aged
21-30 years at the time of oocyte donation (group A) produced
significantly more oocytes per stimulated cycle when compared
with donors aged 31-40 years (group B) (16.8 ± 6.9 and 15.1
± 8 . 1 respectively; P < 0.05), the fertilization rates and
numbers of embryos transferred per attempt were similar.
More importantly, comparable clinical and ongoing/delivered
pregnancy rates resulted. As a measure of the clinical efficacy
of the embryos produced, the ratios of the number of ongoing
and delivered pregnancies per number of embryos transferred
were calculated and found to be similar (group A, 6.4%; group
B, 7.3%; P = 0.48). Furthermore, although it has been observed
that spontaneous abortions occur more frequently with increas-
ing age in a retrospective analysis of reproductive histories
(Warburton and Fraser, 1964) and a previous analysis of donor
oocyte data (Levran et al., 1991), this was not evident in our
comparison (group A, 20.0%; group B, 12.2%; P = 0.25).
Perhaps, as preliminary studies of preimplantation aneuploidy
suggest, an older subgroup of women (>40 years old) must
be studied for a higher spontaneous abortion rate to be readily
evident (Grifo et al, 1994; Munne et al., 1995).
The issue of whether older women are efficient oocyte
donors is of great practical importance. Ideally, the most
suitable oocyte donor is of proven fertility, has completed her
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own family and is motivated by altruism. Such a woman is
often between the ages of 31 and 40 years and represents
the majority of women participating in our oocyte donation
programme (Sauer et al, 1994). Furthermore, as requests
increase from women with previous donor oocyte success to
obtain oocytes from the same donor so as to achieve genetic
siblings, data are needed to inform recipients of the efficacy
of oocytes from proven but ageing donors (Sauer and Paulson,
1993). The results of dais study are encouraging. Women of
proven fertility should not be excluded from donating oocytes
simply because of their age. As previous human and baboon
experience with the uterine lavage recovery of pre-embryos
suggests, even among a cohort of females of proven fertility,
variation exists (Sauer et al, 1987; Pope et al, 1983). Although
ageing affects fertility, its effects may be less in this subclass
of 'super-fertile' women.
It is our general policy to accept anonymous donors up to
the age of 35 years. For recipients providing their own
oocyte donor, the age restriction is 40 years. In addition to
recommended screening tests (American Fertility Society,
1993), we have been measuring the menstrual cycle day 3
follicle stimulating hormone concentrations of potential donors.
To be accepted as a donor, the concentration must be <15 IU/
1. There were two women with regular menses, aged 37 and
40 years, who were rejected as oocyte donors based solely on
an elevated day 3 follicle stimulating hormone concentration.
Each was a sister of the potential recipient If poor response
is defined as stimulation resulting in less than six recovered
oocytes, a poor response was observed with <2% of new
donors aged 21-30 years and with <5% new donors aged 31—
40 years. Poor responders are not allowed to donate repetitively.
With repetitive donation, we have not observed an attenuation
in cycle performance. There have been women who have
donated periodically for up to 3 years.
One drawback of using oocytes from older donors is the
increased risk of fetal chromosomal anomalies. It is estimated
that a woman of 21 years of age has a 1 in 526 chance of
having a child with a chromosomal abnormality, aged 25 years
has a 1 in 476 chance, aged 30 years has a 1 in 385 chance,
aged 35 years has a 1 in 178 chance and aged 40 years has a
1 in 63 chance (Hook, 1981). Therefore, theoretically, oocytes
from a donor aged 35 years would have three times the risk
of the birth of a chromosomally abnormal infant when com-
pared with oocytes from a 21 year old, and oocytes from a donor
aged 40 years would have eight times the risk. Accordingly, all
recipients are offered prenatal genetic screening, and women
utilizing donors 5*35 years of age are offered prenatal genetic
testing, hi one instance, a trisomy 21 infant was delivered by
a 53 year old recipient who utilized the oocytes of a 35 year
old designated donor. Prenatal genetic screening had been
negative and prenatal genetic testing had been declined in
this case.
Another potential drawback is that the older donors produce
less oocytes per cycle (group B, 15.1 ± 8 . 1 versus group A,
16.8 ± 6.9; P < 0.05). Although statistically significant, this
represents a difference of less than two oocytes. Whether this
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pregnancy rate when frozen-thawed embryo transfers are
analysed has to be determined.
In conclusion, there exists a cohort of fertile women who
resist the decreasing fecundity and increasing spontaneous
abortion rates associated with ageing. With careful screening,
many women of proven fertility can donate oocytes until the
age of 40 years with an efficacy equal to that of younger
women. Given the relative shortage of suitable oocyte donors
and increasing requests from recipients with previous donor
oocyte babies to obtain oocytes from the same, now older,
donor, the findings of this study are of practical clinical
importance.
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